Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
464 studies found for:    "Diabetic Angiopathies"
Show Display Options
Rank Status Study
1 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
2 Terminated Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
Conditions: Foot Ulcer, Diabetic;   Diabetic Angiopathies
Intervention: Drug: bemiparin (low molecular weight heparin)
3 Completed Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Retinal Diseases;   Eye Diseases;   Diabetic Angiopathies;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
4 Completed Trial Comparing Different Medical Devices for Infragenual Dilatation
Conditions: Diabetic Angiopathies;   Intermittent Claudication
Interventions: Procedure: Infragenual dilatation;   Procedure: Infragenual dilatation with stenting;   Procedure: Infragenual dilatation with cutting balloon;   Procedure: Laser therapy
5 Completed Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
Condition: Diabetic Vascular Complications
Intervention:
6 Unknown  Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
Conditions: Disease Management;   Diabetes Complications;   Diabetic Vascular Complications;   Diabetic Neuropathy;   Diabetic Nephropathy;   Diabetic Retinopathy
Intervention: Other: ADEC Program
7 Completed
Has Results
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen® pegaptanib sodium
8 Recruiting Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Other: AMNIOEXCEL;   Other: Standard of Care, Diabetic Foot Ulcers
9 Recruiting Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen Therapy
Condition: Diabetic Peripheral Vascular Disease
Intervention:
10 Not yet recruiting Analysis of Aqueous and Vitreous Humor
Conditions: Proliferative Diabetic Retinopathy;   Macular Degeneration;   Macular Hole;   Neovascular Glaucoma
Intervention: Drug: Ranibizumab
11 Unknown  To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation
Conditions: Macular Edema;   Diabetic Retinopathy;   Visual Field Loss
Interventions: Procedure: PASCAL laser;   Procedure: Conventional laser
12 Completed The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
Conditions: Diabetes Mellitus, Type 1;   Insulin;   Retina;   Regional Blood Flow
Interventions: Drug: Insulin;   Drug: Glucose
13 Completed Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life
Conditions: Diabetic Foot Ulcer;   Diabetes
Intervention: Device: Hyperbaric oxygen therapy
14 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
15 Completed Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
Condition: Chronic Diabetic Foot Ulcers
Interventions: Drug: Soluble beta-glucan (SBG);   Drug: Placebo comparator
16 Completed Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration: a Pilot Study
Condition: Diabetic Foot Ulcer
Intervention: Behavioral: Nursing counseling
17 Unknown  Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Procedure: Vitrectomy
18 Terminated Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride;   Drug: Oral placebo capsules
19 Recruiting Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
Conditions: Peripheral Arterial Disease;   Diabetic Foot
Interventions: Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
20 Recruiting Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot
Conditions: Diabetic Foot;   Lower Limb Ischemia
Intervention: Biological: Mesenchymal stem cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years